Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Patrick Hwu
Based on 108 articles published since 2009
(Why 108 articles?)
||||
Expertise Level
The expertise of Patrick Hwu ranks in the
  • Top 0.06%
  • ... of 105,439 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 108 articles on the topic.
Graphical view (beta)
Get your prestigious
World Expert badge
similar to this:
 
Aliases Hwu, P   ·   Hwu, Patrick
Work Locations
Details
Most likely:    University of Texas Houston   Contact    
2019
  • Massachusetts General Hospital Cancer Center, Boston, MA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA. · Sarah Cannon Research Institute/Florida Cancer Specialists & Research Institute, Sarasota, FL, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Genentech, Inc., South San Francisco, CA, USA. · Pubmed 31171876
2018
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational and Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 30297909
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 29361468
  • Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA. · Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA. · Molecular & Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Celsius Therapeutics, Cambridge, MA, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany. · Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Department of Surgical Oncology, Boston, MA, USA. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA. Electronic address: · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Ludwig Center for Cancer Research at MIT, Boston, MA, USA; Massachusetts Institute of Technology, Department of Biology, Cambridge, MA, USA. · Pubmed 30388455
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas Health Science Center at Houston, Houston, TX, USA. · Corrona, LLC, Southborough, MA, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA; California Pacific Medical Center Research Institute, San Francisco, CA, USA. Electronic address: · Pubmed 30347335
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Moffitt Cancer Center, 12902 USF Magnolia Dr., Tampa, FL, 33612, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · California Pacific Medical Center, 2323 Sacramento St. #2, San Francisco, CA, 94115, USA. · The University of Texas Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr., Gilbert, AZ, 85234, USA. · Pubmed 28612140
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Memgen, LLC Houston, TX, 77046, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX, 77054, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX, 77054, USA. · Pubmed 29129918
  • Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States; Department of Neurosurgery, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. Electronic address: · Pubmed 28916225
  • Department of Melanoma Medical Oncology Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Lymphoma/Myeloma Unit 903, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Institute for Applied Cancer Sciences Unit 1956, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Clinical Cancer Prevention Unit 1013, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Cancer Imaging Systems Unit 1907, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Immunology Unit 901, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Synta Pharmaceuticals Inc., 45 Hartwell Avenue, Lexington, MA, 02421, USA. · Department of Melanoma Medical Oncology Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Pubmed 28878208
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Graduate Program in Immunology, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. · Department of Chemical and Biomolecular Engineering, Cullen College of Engineering, University of Houston, Texas. · Graduate Program in Biostatistics, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas. · Immunology Platform, Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28754817
  • Center for Cancer Immunology Research, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul, Republic of Korea. · Department of Systems Biology, MD Anderson Cancer Center, Houston, Texas. · Center for Cancer Immunology Research, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Departments of Melanoma Medical Oncology and Immunology, MD Anderson Cancer Center, Houston, Texas. · Pubmed 28630054
  • University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 28500560
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28263973
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28062513
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
2016
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26601872
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
  • Wolfson Wohl Cancer Research Centre, Institute for Cancer Sciences, University of Glasgow, Garscube Estate, Bearsden, Glasgow G61 1BD, UK. · West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow G31 2ER, United Kingdom. · Department of Surgery, Bankstown Hospital, Eldridge Road, Bankstown, Sydney, New South Wales 2200, Australia. · South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, New South Wales 2170, Australia. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Departments of Pathology and Translational Molecular Pathology, Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 27762323
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland. · Pubmed 27697858
  • Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA. · Pubmed 27678219
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 27667683
  • DDepartment of Melanoma Medical Oncology, University of Texas-MD Anderson Cancer Center, 1515 Holcolmbe Blvd., Houston, TX, 77030, USA. · Department of Immunology, University of Texas-MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · DDepartment of Melanoma Medical Oncology, University of Texas-MD Anderson Cancer Center, 1515 Holcolmbe Blvd., Houston, TX, 77030, USA. · Pubmed 27595932
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27458138
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, Moffitt Cancer Center, Tampa, FL 22612, USA. · Pubmed 27153543
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
2015
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Abramson Cancer Center and the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Pubmed 25980594
  • Department of Dermatology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; · Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland; · Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; · Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland; · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland; Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; Swiss Institute for Cancer Research, École polytechnique fédérale de Lausanne, 1015 Lausanne, Switzerland; · Division of Dermatology, and Departments of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland. · Department of Dermatology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; · Pubmed 26607445
  • Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26216417
  • Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Foundation Medicine, 150 Second Street, Cambridge, MA, 02141, USA. · Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Foundation Medicine, 150 Second Street, Cambridge, MA, 02141, USA. · Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Foundation Medicine, 150 Second Street, Cambridge, MA, 02141, USA. · Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA, 92093, USA. · Pubmed 25886620
  • Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25795007
  • Department of Cancer Biology, Unit 0173, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · The University of Texas Health Science Center at Houston, 1825 Pressler Street, Houston, Texas 77030, USA. · Department of Gynecologic Oncology, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Canada's Michael Smith Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada. · Institute of Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · 1] Department of Cancer Biology, Unit 0173, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA [2] Department of Gynecologic Oncology, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Department of Melanoma Medical Oncology, Unit 0430, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Department of Experimental Therapeutics, Unit 1950, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · 1] Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan 52621, Israel [2] Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel. · Pubmed 25686251
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Donald A. Adam Comprehensive Melanoma Research Center, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Lion Biotechnologies, Woodland Hills, Los Angeles, California. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida. Lion Biotechnologies, Woodland Hills, Los Angeles, California. · Pubmed 25472998
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Dermatology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Cancer Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. Electronic address: · Pubmed 25148578
2014
  • Patrick A. Ott and Anna C. Pavlick, New York University Cancer Institute, New York, NY · Omid Hamid and Peter D. Boasberg, The Angeles Clinic and Research Institute, Los Angeles, CA · Harriet Kluger and Mario Sznol, Yale Cancer Center, New Haven, CT · Kevin B. Kim and Patrick Hwu, University of Texas MD Anderson Cancer Center, Houston, TX · Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, and Thomas A. Davis, Celldex Therapeutics, Hampton, NJ. · Pubmed 25267741
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; and. · 3M Drug Delivery Systems Division, 3M Company, St. Paul, MN 55144. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Pubmed 25252955
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25165098
2012
  • Department of Melanoma Medical Oncology, The Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 22421945
2017
  • Departments of *Stem Cell Transplantation and Cellular Therapy †Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China ‡Melanoma Medical Oncology §Cancer Systems Imaging ∥Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 27681378
2016
  • Departments of aMelanoma Medical Oncology bBiostatistics cSystems Biology, UT MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 27540836
  • From the Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 26825879
2014
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 904, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Pubmed 24890028
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
  • *Department of Melanoma Medical Oncology †Division of Pediatrics, MD Anderson Cancer Center, Houston, TX ‡Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD ∥Lion Biotechnologies, Woodland Hills, CA §Sidra Medical and Research Hospital, Doha, Qatar. · Pubmed 25304728
2013
  • M.D. Anderson Cancer Center, University of Texas, Houston, TX 77054, USA. · Pubmed 23603862
  • Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 23576709
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23248257
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 23922205
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 23560068
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23455713
  • Departments of Melanoma Medical Oncology and Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23204132
  • Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23147350
2012
  • Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77054, USA. · Pubmed 22484193
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22453018
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23032743
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22809251
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas 77030, USA. · Pubmed 22668797
  • Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22355009
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22274951
  • Departments of Melanoma Medical Oncology, Systems Biology, Biostatistics, Pathology, Experimental Therapeutics, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22223528
  • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23105141
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22850568
  • Department of Melanoma Medical Oncology, Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 22761473
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 22584956
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22307139
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22180178
  • Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 22130161
2011
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 430, Houston, TX 77030, USA. · Pubmed 21111964
  • Departments of aMelanoma Medical Oncology bBioinformatics cNursing, MD, Anderson Cancer Center, University of Texas, Houston, Texas, USA. · Pubmed 21102360
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21738104
  • Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21632855
  • Department of Melanoma Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20978276
  • Department of Diagnostic Radiology, M. D. Anderson Cancer Center, T. Boone Pickens Academic Tower, Houston, TX 77030, USA. · Pubmed 22109345
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21389874
  • Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21382485
  • Department of Melanoma/Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 21169870
  • Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21166498
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 21150567
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 20960525
2010
  • Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20881508
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 20859231
  • Department of Immunology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21098714
  • Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20948439
  • Departments of Melanoma Medical Oncology and Experimental Diagnostic Imaging, The Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20889916
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20386469
  • Department of Pathology, Section of Ophthalmology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20375921
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19952963
  • Department of Melanoma Medical Oncology, Graduate School of Biomedical Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19949105
  • Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. · Pubmed 19935383
2009
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, 1515 Holcombe Building, Unit 430, Houston, TX 77030, USA. · Pubmed 19521262
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19506454
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19440934
  • Department of Melanoma Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, Houston 77030, Texas, USA. · Pubmed 19430405
  • Department of Immunology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19879162
  • Department of Melanoma Medical Oncology and Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19671763
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19494262
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 108 total) written by Patrick Hwu about Melanoma:

  • Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients. 2019
  • Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. 2018
  • Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. 2018
  • A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade. 2018
  • Association between melanoma and renal-cell carcinoma for sequential diagnoses: A single-center retrospective study. 2018
  • Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. 2018
  • The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy. 2018
  • Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. 2018
  • A phase II study of ipilimumab plus temozolomide in patients with metastatic melanoma. 2017
  • Intratumoral CD40 activation and checkpoint blockade induces T cell-mediated eradication of melanoma in the brain. 2017
Show List of Full Article Records
Google Searches

Learn more about Patrick Hwu using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Texas Houston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Texas Houston
2019
  • Massachusetts General Hospital Cancer Center, Boston, MA, USA. · The Angeles Clinic and Research Institute, Los Angeles, CA, USA. · University of Colorado Cancer Center, Aurora, CO, USA. · Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA. · Sarah Cannon Research Institute/Florida Cancer Specialists & Research Institute, Sarasota, FL, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · MD Anderson Cancer Center, Houston, TX, USA. · Genentech, Inc., South San Francisco, CA, USA. · Pubmed 31171876
2018
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Breast Medical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Head and Neck Surgery, MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, MD Anderson Cancer Center, Houston, TX, USA. · Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, MD Anderson Cancer Center, Houston, TX, USA. · Department of Translational and Molecular Pathology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 30297909
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · Pubmed 29361468
  • Broad Institute of MIT and Harvard, Cambridge, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA. · Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA. · Molecular & Cellular Oncogenesis Program and Melanoma Research Center, The Wistar Institute, Philadelphia, PA, USA. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Celsius Therapeutics, Cambridge, MA, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany. · Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Department of Dermatology, University Hospital Essen, West German Cancer Center, University Duisburg-Essen and the German Cancer Consortium, Essen, Germany. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Brigham and Women's Hospital, Department of Surgical Oncology, Boston, MA, USA. · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Center for Cancer Precision Medicine of Dana-Farber Cancer Institute, Boston, MA, USA; Laboratory for Systems Pharmacology, Harvard Medical School, Boston, MA, USA; Center for Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA; Ludwig Center for Cancer Research at Harvard, Boston, MA, USA. Electronic address: · Broad Institute of MIT and Harvard, Cambridge, MA, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA; Ludwig Center for Cancer Research at MIT, Boston, MA, USA; Massachusetts Institute of Technology, Department of Biology, Cambridge, MA, USA. · Pubmed 30388455
  • The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · The University of Texas Health Science Center at Houston, Houston, TX, USA. · Corrona, LLC, Southborough, MA, USA. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA; California Pacific Medical Center Research Institute, San Francisco, CA, USA. Electronic address: · Pubmed 30347335
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Novartis Pharmaceuticals, East Hanover, NJ, USA. · Vanderbilt University Medical Center, Nashville, TN, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Genentech, San Francisco, CA, USA. · University of California Los Angeles Medical Center, Los Angeles, CA, USA. · Bristol-Myers Squibb, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Memorial Sloan Kettering Cancer Center, New York, NY, USA. · Northwestern University, Chicago, IL, USA. · University Hospital Essen and German Cancer Consortium, Essen, Germany. · Centre Hospitalo-Universitaire Timone, Aix Marseille University, Marseille, France. · Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead NSW, Australia. · Hillman University of Pittsburgh Medical Center Cancer Center, Pittsburgh, PA, USA. · Melanoma Institute Australia and University of Sydney, North Sydney, NSW, Australia; Royal North Shore and Mater Hospitals, St Leonards, NSW, Australia. · Pubmed 29449192
  • Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, Human Genetics and Environmental Sciences, University of Texas School of Public Health, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA. · Department of Cell, Developmental and Cell Biology, Oregon Health and Sciences University, Portland, OR 97239, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Infectious Diseases, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Centre de Recherche de Jouy-en-Josas, Institut National de la Recherche Agronomique, 78352 Jouy-en-Josas, France. · Centre d'Investigation Clinique Biothérapie, Institut Gustave-Roussy, 94805 Villejuif Cedex, France. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 29097493
2017
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Moffitt Cancer Center, 12902 USF Magnolia Dr., Tampa, FL, 33612, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · California Pacific Medical Center, 2323 Sacramento St. #2, San Francisco, CA, 94115, USA. · The University of Texas Banner MD Anderson Cancer Center, 2946 E Banner Gateway Dr., Gilbert, AZ, 85234, USA. · Pubmed 28612140
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Memgen, LLC Houston, TX, 77046, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX, 77054, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77054, USA. · The University of Texas MD Anderson Cancer Center, UTHealth Graduate School of Biomedical Sciences at Houston, Houston, TX, 77054, USA. · Pubmed 29129918
  • Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Neurosurgery, Mayo Clinic, Jacksonville, FL, United States. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, United States. · Department of Therapeutic Radiology, Yale University School of Medicine, Yale-New Haven Hospital, United States; Department of Neurosurgery, Yale University School of Medicine, Yale-New Haven Hospital, United States. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, United States. Electronic address: · Pubmed 28916225
  • Department of Melanoma Medical Oncology Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Lymphoma/Myeloma Unit 903, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Institute for Applied Cancer Sciences Unit 1956, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Clinical Cancer Prevention Unit 1013, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Cancer Imaging Systems Unit 1907, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Department of Immunology Unit 901, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Synta Pharmaceuticals Inc., 45 Hartwell Avenue, Lexington, MA, 02421, USA. · Department of Melanoma Medical Oncology Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Pubmed 28878208
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Graduate Program in Immunology, Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas. · Department of Chemical and Biomolecular Engineering, Cullen College of Engineering, University of Houston, Texas. · Graduate Program in Biostatistics, School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas. · Immunology Platform, Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28754817
  • Center for Cancer Immunology Research, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biochemistry and Molecular Biology, Korea University College of Medicine, Seoul, Republic of Korea. · Department of Systems Biology, MD Anderson Cancer Center, Houston, Texas. · Center for Cancer Immunology Research, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Departments of Melanoma Medical Oncology and Immunology, MD Anderson Cancer Center, Houston, Texas. · Pubmed 28630054
  • University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 28500560
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 28263973
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational and Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 28062513
  • Department of Medical Oncology, Moffitt Cancer Center, Tampa, Florida. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Internal Medicine, Baylor College of Medicine, Houston, Texas. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Clinical Research Program, California Pacific Medical Center, San Francisco, California. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27911979
2016
  • University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26601872
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston. · Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston. · Beth Israel Deaconess Medical Center, Boston, Massachusetts. · Departments of Pathology and Translational and Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston. · Broad Institute, Cambridge, Massachusetts. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston7Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston. · Massachusetts General Hospital, Boston. · California Pacific Medical Center Research Institute, San Francisco. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston11Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston. · Pubmed 27124486
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Lion Biotechnologies, Woodland Hills, CA, 91637, USA. · Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, 770393, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · EMD Serono, Rockland, MA, 02370, USA. · Department of Thoracic Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Unit 904, Houston, TX, 77030, USA. · Department of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA. · Pubmed 27776519
  • Wolfson Wohl Cancer Research Centre, Institute for Cancer Sciences, University of Glasgow, Garscube Estate, Bearsden, Glasgow G61 1BD, UK. · West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow G31 2ER, United Kingdom. · Department of Surgery, Bankstown Hospital, Eldridge Road, Bankstown, Sydney, New South Wales 2200, Australia. · South Western Sydney Clinical School, Faculty of Medicine, University of New South Wales, Liverpool, New South Wales 2170, Australia. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Departments of Pathology and Translational Molecular Pathology, Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Pubmed 27762323
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Division of Translational Medicine, Sidra Medical and Research Center, Doha, Qatar. · Cell Processing Section, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland. · Pubmed 27697858
  • Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA. · Department of Immunology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. University of Texas Graduate School of Biomedical Sciences, Houston, TX 77030, USA. · Pubmed 27678219
  • Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Melanoma Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address: · Pubmed 27667683
  • DDepartment of Melanoma Medical Oncology, University of Texas-MD Anderson Cancer Center, 1515 Holcolmbe Blvd., Houston, TX, 77030, USA. · Department of Immunology, University of Texas-MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · Department of Genitourinary Medical Oncology, University of Texas-MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA. · DDepartment of Melanoma Medical Oncology, University of Texas-MD Anderson Cancer Center, 1515 Holcolmbe Blvd., Houston, TX, 77030, USA. · Pubmed 27595932
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27458138
  • Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 27301722
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Immunology, Moffitt Cancer Center, Tampa, FL 22612, USA. · Pubmed 27153543
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Chicago, Chicago, Illinois. · Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26645196
2015
  • Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Abramson Cancer Center and the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · Massachusetts General Hospital Cancer Center, 55 Fruit Street, Boston, MA 02114, USA. Electronic address: · Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: · Vanderbilt-Ingram Cancer Center, Vanderbilt University, 2220 Pierce Avenue #777, Nashville, TN 37232, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Peter MacCallum Cancer Centre, 2 St Andrews Place, East Melbourne, Vic 3002, Australia. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Jonsson Comprehensive Cancer Center, University of California, Los Angeles, 11-934 Factor Bldg., 10833 Le Conte Ave., Los Angeles, CA 90095-1782, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · Plexxikon Inc., 91 Bolivar Drive, Berkeley, CA 94710, USA. Electronic address: · The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. Electronic address: · Pubmed 25980594
  • Department of Dermatology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; · Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland; · Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; · Institute of Immunobiology, Kantonsspital St. Gallen, 9007 St. Gallen, Switzerland; · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Biochemistry, University of Lausanne, 1066 Epalinges, Switzerland; Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; Swiss Institute for Cancer Research, École polytechnique fédérale de Lausanne, 1015 Lausanne, Switzerland; · Division of Dermatology, and Departments of Microbiology, Immunology, and Molecular Genetics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095; · Department of Oncology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; Ludwig Center for Cancer Research, University of Lausanne, 1011 Lausanne, Switzerland. · Department of Dermatology, University Hospital of Lausanne, 1011 Lausanne, Switzerland; · Pubmed 26607445
  • Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 26216417
  • Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Foundation Medicine, 150 Second Street, Cambridge, MA, 02141, USA. · Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Foundation Medicine, 150 Second Street, Cambridge, MA, 02141, USA. · Department of Investigational Cancer Therapeutics - a Phase I Clinical Trials Program, Unit 455, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. · Foundation Medicine, 150 Second Street, Cambridge, MA, 02141, USA. · Center for Personalized Cancer Therapy, Moores Cancer Center, The University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA, 92093, USA. · Pubmed 25886620
  • Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25795007
  • Department of Cancer Biology, Unit 0173, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · The University of Texas Health Science Center at Houston, 1825 Pressler Street, Houston, Texas 77030, USA. · Department of Gynecologic Oncology, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Canada's Michael Smith Cancer Agency, Vancouver, British Columbia V5Z 4S6, Canada. · Institute of Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · 1] Department of Cancer Biology, Unit 0173, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA [2] Department of Gynecologic Oncology, Unit 1362, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Department of Melanoma Medical Oncology, Unit 0430, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Department of Surgical Oncology, Unit 1484, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · Department of Experimental Therapeutics, Unit 1950, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, Texas 77030, USA. · 1] Ella Institute of Melanoma, Sheba Medical Center, Ramat-Gan 52621, Israel [2] Clinical Microbiology and Immunology, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel. · Pubmed 25686251
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Donald A. Adam Comprehensive Melanoma Research Center, H. Lee Moffitt Cancer Center, Tampa, Florida. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Lion Biotechnologies, Woodland Hills, Los Angeles, California. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. The Immunology Program of the University of Texas Health Science Center, Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, H. Lee Moffitt Cancer Center, Tampa, Florida. Lion Biotechnologies, Woodland Hills, Los Angeles, California. · Pubmed 25472998
  • Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Biostatistics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Dermatology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Cancer Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Hematopathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Experimental Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. · Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA; Department of Systems Biology, MD Anderson Cancer Center, The University of Texas, Houston, Texas, USA. Electronic address: · Pubmed 25148578
2014
  • Patrick A. Ott and Anna C. Pavlick, New York University Cancer Institute, New York, NY · Omid Hamid and Peter D. Boasberg, The Angeles Clinic and Research Institute, Los Angeles, CA · Harriet Kluger and Mario Sznol, Yale Cancer Center, New Haven, CT · Kevin B. Kim and Patrick Hwu, University of Texas MD Anderson Cancer Center, Houston, TX · Ronit Simantov, Elizabeth Crowley, Jennifer A. Green, Thomas Hawthorne, and Thomas A. Davis, Celldex Therapeutics, Hampton, NJ. · Pubmed 25267741
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; and. · 3M Drug Delivery Systems Division, 3M Company, St. Paul, MN 55144. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030; University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030; · Pubmed 25252955
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Cancer Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25165098
2012
  • Department of Melanoma Medical Oncology, The Center for Cancer Immunology Research, University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 22421945
2017
  • Departments of *Stem Cell Transplantation and Cellular Therapy †Shanghai Pulmonary Hospital, Tongji University School of Medicine, Shanghai, China ‡Melanoma Medical Oncology §Cancer Systems Imaging ∥Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 27681378
2016
  • Departments of aMelanoma Medical Oncology bBiostatistics cSystems Biology, UT MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 27540836
  • From the Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 26825879
2014
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Box 904, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. · Pubmed 24890028
  • aHealth Science Center, University of Oklahoma, Oklahoma City, Oklahoma Departments of bMelanoma Medical Oncology cPalliative Care and Rehabilitative Medicine dBiostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 24743052
  • *Department of Melanoma Medical Oncology †Division of Pediatrics, MD Anderson Cancer Center, Houston, TX ‡Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD ∥Lion Biotechnologies, Woodland Hills, CA §Sidra Medical and Research Hospital, Doha, Qatar. · Pubmed 25304728
2013
  • M.D. Anderson Cancer Center, University of Texas, Houston, TX 77054, USA. · Pubmed 23603862
  • Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77230, USA. · Pubmed 23576709
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23248257
  • Department of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 23922205
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 23560068
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 23455713
  • Departments of Melanoma Medical Oncology and Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23204132
  • Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23147350
2012
  • Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77054, USA. · Pubmed 22484193
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22453018
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 23032743
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22809251
  • Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, Texas 77030, USA. · Pubmed 22668797
  • Department of Investigational Cancer Therapeutics, Phase I Clinical Trials Program, Division of Cancer Medicine, MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 22355009
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22274951
  • Departments of Melanoma Medical Oncology, Systems Biology, Biostatistics, Pathology, Experimental Therapeutics, and Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 22223528
  • Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 23105141
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 22850568
  • Department of Melanoma Medical Oncology, Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 22761473
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 22584956
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22307139
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 22180178
  • Department of Melanoma Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA. · Pubmed 22130161
2011
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 430, Houston, TX 77030, USA. · Pubmed 21111964
  • Departments of aMelanoma Medical Oncology bBioinformatics cNursing, MD, Anderson Cancer Center, University of Texas, Houston, Texas, USA. · Pubmed 21102360
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21738104
  • Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21632855
  • Department of Melanoma Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 20978276
  • Department of Diagnostic Radiology, M. D. Anderson Cancer Center, T. Boone Pickens Academic Tower, Houston, TX 77030, USA. · Pubmed 22109345
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21389874
  • Department of Lymphoma and Myeloma, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 21382485
  • Department of Melanoma/Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA. · Pubmed 21169870
  • Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 21166498
  • Departments of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA. · Pubmed 21150567
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77054, USA. · Pubmed 20960525
2010
  • Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20881508
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030-4009, USA. · Pubmed 20859231
  • Department of Immunology, The University of Texas, M. D. Anderson Cancer Center, Houston, Texas, USA. · Pubmed 21098714
  • Section of Transplantation Immunology, Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20948439
  • Departments of Melanoma Medical Oncology and Experimental Diagnostic Imaging, The Center for Cancer Immunology Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA. · Pubmed 20889916
  • Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 20386469
  • Department of Pathology, Section of Ophthalmology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 20375921
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA. · Pubmed 19952963
  • Department of Melanoma Medical Oncology, Graduate School of Biomedical Sciences, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19949105
  • Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, 77030, USA. · Pubmed 19935383
2009
  • Department of Melanoma Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, 1515 Holcombe Building, Unit 430, Houston, TX 77030, USA. · Pubmed 19521262
  • Department of Melanoma Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19506454
  • Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19440934
  • Department of Melanoma Medical Oncology, M. D. Anderson Cancer Center, The University of Texas, Houston 77030, Texas, USA. · Pubmed 19430405
  • Department of Immunology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19879162
  • Department of Melanoma Medical Oncology and Department of Systems Biology, The University of Texas, MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19671763
  • Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. · Pubmed 19494262
Unspecified
2018
  • Department of Melanoma Medical Oncology. · Department of Lymphoma/Myeloma. · Department of Sarcoma Medical Oncology. · Institute for Applied Cancer Science. · Department of Gynecologic Oncology and Reproductive Medicine. · Department of Cancer Imaging Systems. · The University of Texas MD Anderson Cancer Center, Houston, TX; Merrimack Pharmaceuticals, Cambridge, MA. · Center for RNA Interference and Non-coding RNA. · Department of Biostatistics. · Pubmed 29267866
9 Other Locations Show
Yearly article counts 1711148891814117
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.